Endocrinology

Top Story

Top 5 online obesity stories

August 28, 2015

Endocrine Today has compiled a list of the top five obesity stories posted in the last month.

Healio.com/Endocrinology readers were interested in long-term follow-up of sleeve gastrectomy, FDA approval of a balloon device for obesity treatment, the Treat and Reduce Obesity Act, and more.

FDA News

FDA: DPP-IV inhibitors may cause severe joint pain

August 28, 2015
The FDA recently a warned that the medications Januvia, Onglyza, Tradjenta and Nesina may cause joint pain that is severe and disabling, according to a press release. It…
In the Journals

Growth hormone reduces osteoporotic fracture risk in older women

August 28, 2015
Older women with osteoporosis treated with growth hormone showed a reduced risk for fracture and improved bone density that continued for years after stopping treatment…
FDA News

FDA approves Synjardy for type 2 diabetes

August 28, 2015
The FDA has approved Synjardy to control blood glucose levels in adults with type 2 diabetes, according to a release from Boehringer Ingelheim Pharmaceuticals and Eli…
FDA News

FDA: Lots of OmniPod insulin management system recalled

August 28, 2015
In early July, Insulet Corporation initiated a voluntary recall of 40,846 boxes of the OmniPod Insulin Management System, according to an FDA press release.It was…
More News Headlines »
CME
Obesity Consults

Obesity Consults: Volume 2, Number 5
Practical Guide to Medications Approved for Chronic Weight Management

This activity is supported by educational grants from Eisai, Inc. and Vivus, Inc.

Several pharmacologic options for the management of obesity have been approved by the US FDA, giving clinicians a range…
More »
Meeting News Coverage Video
VIDEO: Chef integrates food and medicine in promotion of cardiometabolic health

VIDEO: Chef integrates food and medicine in promotion of cardiometabolic health

August 10, 2015
NEW ORLEANS — Chef Leah Sarris, program director at the Goldring Center for Culinary Medicine at Tulane…
More »
CME
Avoiding “Loss of Chance”…Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

Avoiding “Loss of Chance”…Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Current Issues
View the Current Issues
morganatic-roan
morganatic-roan